Recent Advances in the Development of Pyrazolopyridines as Anticancer Agents

被引:4
|
作者
Gu, Xiaotong [1 ]
Ma, Shutao [1 ]
机构
[1] Shandong Univ, Cheeloo Coll Med, Sch Pharmaceut Sci, Dept Med Chem,Key Lab Chem Biol,Minist Educ, 44 West Culture Rd, Jinan 250012, Peoples R China
基金
中国国家自然科学基金;
关键词
Cancer; anticancer agents; pyrazolopyridines; heterocyclic compounds; biological activity; structures-activity relationship; MICROWAVE-ASSISTED SYNTHESIS; BIOLOGICAL EVALUATION; KINASE INHIBITORS; POTENT ANTITUMOR; DERIVATIVES; DESIGN; IDENTIFICATION; DISCOVERY; ACTIVATOR; CANCER;
D O I
10.2174/1871520621666210901102832
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer, especially malignant tumor, is a serious threat to people's life and health. It is recognized as an enormous challenge in the 21st century. Continuous efforts are needed to overcome this problem. Pyrazolopyridine nucleus, similar in structure to purine, shows a variety of biological activities, which is mainly attributed to the antagonistic nature towards the natural purines in many biological processes. This has aroused enormous attention for many researchers. At present, a large number of new chemical entities containing pyrazolopyridine nucleus have been found as anticancer agents. In this review we summarize novel pyrazolopyridine-containing derivatives with biological activities. Furthermore, we outline the relationships between the structures of variously modified pyrazolopyridines and their anticancer activity.
引用
收藏
页码:1643 / 1657
页数:15
相关论文
共 50 条
  • [1] Recent Advances in Development of Polyphenols as Anticancer Agents
    Thota, Sreekanth
    Rodrigues, Daniel Alencar
    Barreiro, Eliezer J.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (15) : 1265 - 1269
  • [2] Recent Advances in the Development of Pyrazole Derivatives as Anticancer Agents
    Zhang, Yingqian
    Wu, Chenyuan
    Zhang, Nana
    Fan, Rui
    Ye, Yang
    Xu, Jun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [3] Recent Advances in the Development of Indazole-based Anticancer Agents
    Dong, Jinyun
    Zhang, Qijing
    Wang, Zengtao
    Huang, Guang
    Li, Shaoshun
    CHEMMEDCHEM, 2018, 13 (15) : 1490 - 1507
  • [4] Recent advances in the development of celecoxib analogs as anticancer agents: A review
    Abdelhaleem, Eman F.
    Kassab, Asmaa E.
    El-Nassan, Hala B.
    Khalil, Omneya M.
    ARCHIV DER PHARMAZIE, 2022, 355 (12)
  • [5] Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents
    Liu, Yang
    Li, Yijing
    Yu, Shenghui
    Zhao, Guisen
    CURRENT DRUG TARGETS, 2012, 13 (11) : 1432 - 1444
  • [6] Recent advances of benzimidazole as anticancer agents
    Venugopal, Sneha
    Kaur, Balwinder
    Verma, Anil
    Wadhwa, Pankaj
    Magan, Muskan
    Hudda, Sharwan
    Kakoty, Violina
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (02) : 357 - 376
  • [7] Review: recent advances and future development of metal complexes as anticancer agents
    Jia, Pengpeng
    Ouyang, Ruizhuo
    Cao, Penghui
    Tong, Xiao
    Zhou, Xia
    Lei, Tian
    Zhao, Yuefeng
    Guo, Ning
    Chang, Haizhou
    Miao, Yuqing
    Zhou, Shuang
    JOURNAL OF COORDINATION CHEMISTRY, 2017, 70 (13) : 2175 - 2201
  • [8] Recent Advances in the Development of Fatty Acid Synthase Inhibitors as Anticancer Agents
    Singh, Shailendra
    Karthikeyan, Chandrabose
    Moorthy, N. S. Hari Narayana
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (18) : 1820 - 1837
  • [9] Recent Advances in Copper Intercalators as Anticancer Agents
    Devi, C. Shobha
    Thulasiram, B.
    Aerva, Rajeshwar Rao
    Nagababu, Penumaka
    JOURNAL OF FLUORESCENCE, 2018, 28 (05) : 1195 - 1205
  • [10] Recent Advances in Copper Intercalators as Anticancer Agents
    C. Shobha Devi
    B. Thulasiram
    Rajeshwar Rao Aerva
    Penumaka Nagababu
    Journal of Fluorescence, 2018, 28 : 1195 - 1205